FGC
NKTR icon

Financial Gravity Companies’s Nektar Therapeutics NKTR Stock Holding History

Financial Gravity Companies’s Portfolio NKTR Stock Details NKTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		$14K Buy
+21
New +$12.7K 0.01% 530
2018
Q1 		$2K Hold
2
– – ﹤0.01% 978
2017
Q4 		$2K Buy
+2
New +$1.18K ﹤0.01% 961

Other funds holding NKTR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Financial Gravity Companies's NKTR Position: Q4 2018 in Review

Financial Gravity Companies opened a new position in Nektar Therapeutics (NKTR) in Q4 2018: 21 shares worth $14K. The stake represents 0.01% of the portfolio and ranks #530 among its holdings. This is a return to the name: Financial Gravity Companies previously reported a position in NKTR as recently as Q1 2018.

Financial Gravity Companies first reported a position in NKTR in Q4 2017 and has held it in 3 quarters since. 343 funds tracked by Wall St. Rank hold NKTR as of Q4 2018.

  • Financial Gravity Companies held 21 shares of Nektar Therapeutics worth $14K as of Q4 2018.
  • Nektar Therapeutics was a new Financial Gravity Companies position in Q4 2018.
  • Nektar Therapeutics made up 0.01% of Financial Gravity Companies's portfolio in Q4 2018, its #530 holding.
  • Financial Gravity Companies first reported a position in Nektar Therapeutics in Q4 2017 and has held it in 3 quarters since.
  • 343 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q4 2018.

Based on Financial Gravity Companies's 13F filing for Q4 2018, filed 4 Feb 2019.